Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain

  1. Moreno, S.
  2. Rivero, A.
  3. Ventayol, P.
  4. Falcó, V.
  5. Torralba, M.
  6. Schroeder, M.
  7. Neches, V.
  8. Vallejo-Aparicio, L.A.
  9. Mackenzie, I.
  10. Turner, M.
  11. Harrison, C.
Aldizkaria:
Infectious Diseases and Therapy

ISSN: 2193-6382 2193-8229

Argitalpen urtea: 2023

Alea: 12

Zenbakia: 8

Orrialdeak: 2039-2055

Mota: Artikulua

DOI: 10.1007/S40121-023-00840-Y GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak